Compare FBIN & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FBIN | CAI |
|---|---|---|
| Founded | 1988 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Building Products | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 6.2B |
| IPO Year | 2011 | 2025 |
| Metric | FBIN | CAI |
|---|---|---|
| Price | $39.36 | $29.84 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 11 | 11 |
| Target Price | ★ $54.60 | $30.91 |
| AVG Volume (30 Days) | 2.0M | ★ 4.7M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 2.58% | N/A |
| EPS Growth | N/A | ★ 69.79 |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $4,463,200,000.00 | $812,033,000.00 |
| Revenue This Year | $2.68 | $25.24 |
| Revenue Next Year | $3.60 | $22.32 |
| P/E Ratio | $3,975.00 | ★ N/A |
| Revenue Growth | N/A | ★ 96.97 |
| 52 Week Low | $32.34 | $14.19 |
| 52 Week High | $64.84 | $33.66 |
| Indicator | FBIN | CAI |
|---|---|---|
| Relative Strength Index (RSI) | 31.33 | 70.12 |
| Support Level | $37.87 | $17.15 |
| Resistance Level | $40.26 | N/A |
| Average True Range (ATR) | 1.31 | 1.41 |
| MACD | -0.16 | 0.32 |
| Stochastic Oscillator | 8.48 | 81.19 |
Fortune Brands is a US-based homebuilding products company that sells building-related products serving R&R and new construction markets. The company operates in three segments: water, outdoors, and security. Water innovation, including plumbing fixtures and faucets, accounts for around 55% of total sales and features brands such as Moen, House of Rohl, and Aqualisa. The outdoors segment includes decking, railing, and doors and makes up 30% of total sales, featuring brands such as Larson, Fiberon, and Therma-Tru. The security segment, which includes smart residential padlocks, accounts for the remaining 15% of sales and features brands such as MasterLock, SentrySafe, Yale, and AmericanLock.
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.